Anti-VEGF monotherapy treatment strategies for neovascular AMD

Jaclyn L. Kovach; Stephen G. Schwartz; Harry W. Flynn; Ingrid U. Scott

doi:10.1007/978-1-61779-606-7_23

Anti-VEGF monotherapy treatment strategies for neovascular AMD

Jaclyn L. Kovach, Stephen G. Schwartz, Harry W. Flynn, Ingrid U. Scott

Research output: Chapter in Book/Report/Conference proceeding › Chapter

Abstract

This chapter provides a review of the discovery of anti-vascular endothelial growth factor (VEGF) agents, the evolution of drug development, and the refinement of evidence-based treatment strategies for neovascular AMD.

Original language	English (US)
Title of host publication	Studies on Retinal and Choroidal Disorders
Publisher	Humana Press Inc.
Pages	479-499
Number of pages	21
ISBN (Electronic)	9781617796067
ISBN (Print)	9781617796050
DOIs	https://doi.org/10.1007/978-1-61779-606-7_23
State	Published - Jan 1 2012

All Science Journal Classification (ASJC) codes

General Biochemistry, Genetics and Molecular Biology

Access to Document

10.1007/978-1-61779-606-7_23

Cite this

@inbook{473b483eb9e2461096d7b8ac0e8d2f21,

title = "Anti-VEGF monotherapy treatment strategies for neovascular AMD",

abstract = "This chapter provides a review of the discovery of anti-vascular endothelial growth factor (VEGF) agents, the evolution of drug development, and the refinement of evidence-based treatment strategies for neovascular AMD.",

author = "Kovach, {Jaclyn L.} and Schwartz, {Stephen G.} and Flynn, {Harry W.} and Scott, {Ingrid U.}",

year = "2012",

month = jan,

day = "1",

doi = "10.1007/978-1-61779-606-7_23",

language = "English (US)",

isbn = "9781617796050",

pages = "479--499",

booktitle = "Studies on Retinal and Choroidal Disorders",

publisher = "Humana Press Inc.",

}

TY - CHAP

T1 - Anti-VEGF monotherapy treatment strategies for neovascular AMD

AU - Kovach, Jaclyn L.

AU - Schwartz, Stephen G.

AU - Flynn, Harry W.

AU - Scott, Ingrid U.

PY - 2012/1/1

Y1 - 2012/1/1

N2 - This chapter provides a review of the discovery of anti-vascular endothelial growth factor (VEGF) agents, the evolution of drug development, and the refinement of evidence-based treatment strategies for neovascular AMD.

AB - This chapter provides a review of the discovery of anti-vascular endothelial growth factor (VEGF) agents, the evolution of drug development, and the refinement of evidence-based treatment strategies for neovascular AMD.

UR - http://www.scopus.com/inward/record.url?scp=85027317395&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85027317395&partnerID=8YFLogxK

U2 - 10.1007/978-1-61779-606-7_23

DO - 10.1007/978-1-61779-606-7_23

M3 - Chapter

AN - SCOPUS:85027317395

SN - 9781617796050

SP - 479

EP - 499

BT - Studies on Retinal and Choroidal Disorders

PB - Humana Press Inc.

ER -

Anti-VEGF monotherapy treatment strategies for neovascular AMD

Abstract

All Science Journal Classification (ASJC) codes

Access to Document

Other files and links

Fingerprint

Cite this